Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 6/2022

14.10.2021 | Head and Neck

Nomograms predicting prognosis for locally advanced hypopharyngeal squamous cell carcinoma

verfasst von: Huiyun Yang, Mengsi Zeng, Sudan Cao, Long Jin

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to construct nomograms to predict the overall survival (OS) and cancer-specific survival (CSS) for patients with locally advanced hypopharyngeal squamous cell carcinoma (HSCC).

Methods

864 patients with locally advanced HSCC during 2010–2015 from the surveillance, epidemiology and end results (SEER) database were selected. After classifying continuous data by risk, Cox regression analyses were applied to detect significant independent prognostic factors, with which nomograms were established. To evaluate the value of nomograms, concordance index (C-index), area under the receiver-operating characteristic (ROC) curve (AUC), calibration curves, and decision curve analysis (DCA), Kaplan–Meier analysis was adopted. The efficacy of surgery in different risk groups was also studied to figure out people who can benefit from surgery.

Results

A total of 864 locally advanced HSCC patients were randomized into the training cohort (n = 608) and the validation cohort (n = 256). Age, race, tumor size, T stage, N stage, primary site, radiotherapy, and chemotherapy were independent prognostic factors for OS and CSS (except race) and formed the nomograms. The nomograms revealed satisfied performance in C-index, AUC, DCA, and calibration curves, and prevailed over American Joint Committee on Cancer (AJCC) TNM staging system in predicting OS and CSS. After risk stratification, patients of low-risk group resulted in the best outcomes. Patients in moderate-risk may benefit from surgery.

Conclusions

Convenient and well-calibrated nomograms to predict OS and CSS for III/IVA/IVB-stage HSCC patients were set up and assessed and may do a favor to make clinical decisions.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Hall SF, Groome PA, Irish J et al (2008) The natural history of patients with squamou cell carcinoma of the hypopharynx. Laryngoscope 118:1362–1371CrossRef Hall SF, Groome PA, Irish J et al (2008) The natural history of patients with squamou cell carcinoma of the hypopharynx. Laryngoscope 118:1362–1371CrossRef
2.
Zurück zum Zitat Gatta G, Botta L, Sánchez MJ et al (2015) Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study (Oxford, England: 1990). Eur J Cancer 51:2130–2143CrossRef Gatta G, Botta L, Sánchez MJ et al (2015) Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study (Oxford, England: 1990). Eur J Cancer 51:2130–2143CrossRef
3.
Zurück zum Zitat Eckel HE, Bradley PJ (2019) Natural history of treated and untreated hypopharyngeal cancer. Adv Otorhinolaryngol 83:27–34PubMed Eckel HE, Bradley PJ (2019) Natural history of treated and untreated hypopharyngeal cancer. Adv Otorhinolaryngol 83:27–34PubMed
4.
Zurück zum Zitat Takes RP, Strojan P, Silver CE et al (2012) Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck 34:270–281CrossRef Takes RP, Strojan P, Silver CE et al (2012) Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck 34:270–281CrossRef
5.
Zurück zum Zitat Cooper JS, Porter K, Mallin K et al (2009) National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 31:748–758CrossRef Cooper JS, Porter K, Mallin K et al (2009) National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 31:748–758CrossRef
6.
Zurück zum Zitat Hoffman HT, Karnell LH, Shah JP et al (1997) Hypopharyngeal cancer patient care evaluation. Laryngoscope 107:1005–1017CrossRef Hoffman HT, Karnell LH, Shah JP et al (1997) Hypopharyngeal cancer patient care evaluation. Laryngoscope 107:1005–1017CrossRef
7.
Zurück zum Zitat Petersen JF, Timmermans AJ, van Dijk BAC et al (2018) Trends in treatment, incidence and survival of hypopharynx cancer: a 20-year population-based study in the Netherlands. Eur Arch Oto-rhino-laryngol 275:181–189CrossRef Petersen JF, Timmermans AJ, van Dijk BAC et al (2018) Trends in treatment, incidence and survival of hypopharynx cancer: a 20-year population-based study in the Netherlands. Eur Arch Oto-rhino-laryngol 275:181–189CrossRef
8.
Zurück zum Zitat Kuo P, Chen MM, Decker RH et al (2014) Hypopharyngeal cancer incidence, treatment, and survival: temporal trends in the United States. Laryngoscope 124:2064–2069CrossRef Kuo P, Chen MM, Decker RH et al (2014) Hypopharyngeal cancer incidence, treatment, and survival: temporal trends in the United States. Laryngoscope 124:2064–2069CrossRef
9.
Zurück zum Zitat Belcher R, Hayes K, Fedewa S et al (2014) Current treatment of head and neck squamous cell cancer. J Surg Oncol 110:551–574CrossRef Belcher R, Hayes K, Fedewa S et al (2014) Current treatment of head and neck squamous cell cancer. J Surg Oncol 110:551–574CrossRef
10.
Zurück zum Zitat Newman JR, Connolly TM, Illing EA et al (2015) Survival trends in hypopharyngeal cancer: a population-based review. Laryngoscope 125:624–629CrossRef Newman JR, Connolly TM, Illing EA et al (2015) Survival trends in hypopharyngeal cancer: a population-based review. Laryngoscope 125:624–629CrossRef
11.
Zurück zum Zitat Pfister DG, Spencer S, Adelstein D et al (2020) Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 18(7):873–898CrossRef Pfister DG, Spencer S, Adelstein D et al (2020) Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 18(7):873–898CrossRef
12.
Zurück zum Zitat De Laurentiis M, De Placido S, Bianco AR et al (1999) A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patients. Clin Cancer Res 5:4133–4139PubMed De Laurentiis M, De Placido S, Bianco AR et al (1999) A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patients. Clin Cancer Res 5:4133–4139PubMed
13.
Zurück zum Zitat Hou G, Zheng Y, Wei D et al (2019) Development and validation of a SEER-based prognostic nomogram for patients with bone metastatic prostate cancer. Medicine 98:e17197CrossRef Hou G, Zheng Y, Wei D et al (2019) Development and validation of a SEER-based prognostic nomogram for patients with bone metastatic prostate cancer. Medicine 98:e17197CrossRef
14.
Zurück zum Zitat Wu S, Chen JN, Zhang QW et al (2018) A new metastatic lymph node classification-based survival predicting model in patients with small bowel adenocarcinoma: a derivation and validation study. EBioMedicine 32:134–141CrossRef Wu S, Chen JN, Zhang QW et al (2018) A new metastatic lymph node classification-based survival predicting model in patients with small bowel adenocarcinoma: a derivation and validation study. EBioMedicine 32:134–141CrossRef
15.
Zurück zum Zitat Zhang L, Dong D, Li H et al (2019) Development and validation of a magnetic resonance imaging-based model for the prediction of distant metastasis before initial treatment of nasopharyngeal carcinoma: a retrospective cohort study. EBioMedicine 40:327–335CrossRef Zhang L, Dong D, Li H et al (2019) Development and validation of a magnetic resonance imaging-based model for the prediction of distant metastasis before initial treatment of nasopharyngeal carcinoma: a retrospective cohort study. EBioMedicine 40:327–335CrossRef
16.
Zurück zum Zitat Wang CY, Yang J, Zi H et al (2020) Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy. BMC Cancer 20:10CrossRef Wang CY, Yang J, Zi H et al (2020) Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy. BMC Cancer 20:10CrossRef
18.
Zurück zum Zitat Alexandrescu ST, Selaru FM, Diaconescu AS, Zlate CA, Blanita D, Grigorie RT, Zarnescu NO, Herlea V, Popescu I (2021) Prognostic value of lymph node ratio in patients with resected synchronous colorectal liver metastases and less than 12 examined lymph nodes. J Gastrointest Surg. https://doi.org/10.1007/s11605-021-05079-x (Epub ahead of print PMID: 34258674)CrossRefPubMed Alexandrescu ST, Selaru FM, Diaconescu AS, Zlate CA, Blanita D, Grigorie RT, Zarnescu NO, Herlea V, Popescu I (2021) Prognostic value of lymph node ratio in patients with resected synchronous colorectal liver metastases and less than 12 examined lymph nodes. J Gastrointest Surg. https://​doi.​org/​10.​1007/​s11605-021-05079-x (Epub ahead of print PMID: 34258674)CrossRefPubMed
19.
Zurück zum Zitat Tang X, Pang T, Yan WF et al (2020) A novel prognostic model predicting the long-term cancer-specific survival for patients with hypopharyngeal squamous cell carcinoma. BMC Cancer 20(1):1095CrossRef Tang X, Pang T, Yan WF et al (2020) A novel prognostic model predicting the long-term cancer-specific survival for patients with hypopharyngeal squamous cell carcinoma. BMC Cancer 20(1):1095CrossRef
21.
Zurück zum Zitat Reis I, Aguiar A, Alzamora C et al (2016) Locally advanced hypopharyngeal squamous cell carcinoma: single-institution outcomes in a cohort of patients curatively treated either with or without larynx preservation. Radiol Bras 49(1):21–25CrossRef Reis I, Aguiar A, Alzamora C et al (2016) Locally advanced hypopharyngeal squamous cell carcinoma: single-institution outcomes in a cohort of patients curatively treated either with or without larynx preservation. Radiol Bras 49(1):21–25CrossRef
22.
Zurück zum Zitat Joo YH, Cho KJ, Park JO et al (2012) Role of larynx-preserving partial hypopharyngectomy with and without postoperative radiotherapy for squamous cell carcinoma of the hypopharynx. Oral Oncol 48:168–172CrossRef Joo YH, Cho KJ, Park JO et al (2012) Role of larynx-preserving partial hypopharyngectomy with and without postoperative radiotherapy for squamous cell carcinoma of the hypopharynx. Oral Oncol 48:168–172CrossRef
23.
Zurück zum Zitat Visini M, Giger R, Shelan M et al (2021) Predicting factors for oncological and functional outcome in hypopharyngeal cancer. Laryngoscope 131(5):E1543–E1549CrossRef Visini M, Giger R, Shelan M et al (2021) Predicting factors for oncological and functional outcome in hypopharyngeal cancer. Laryngoscope 131(5):E1543–E1549CrossRef
24.
Zurück zum Zitat Zhou Y, Wang X, Si X et al (2020) Surgery for duodenal gastrointestinal stromal tumor: a systematic review and meta-analysis of pancreaticoduodenectomy versus local resection. Asian J Surg 43(1):1–8CrossRef Zhou Y, Wang X, Si X et al (2020) Surgery for duodenal gastrointestinal stromal tumor: a systematic review and meta-analysis of pancreaticoduodenectomy versus local resection. Asian J Surg 43(1):1–8CrossRef
25.
Zurück zum Zitat Azizi M, Peyton CC, Boulware DC et al (2020) Primary tumor size thresholds in stage IA testicular seminoma: implications for adjuvant therapy after orchiectomy and survival. Urol Oncol 38(1):7.e9-7.e18CrossRef Azizi M, Peyton CC, Boulware DC et al (2020) Primary tumor size thresholds in stage IA testicular seminoma: implications for adjuvant therapy after orchiectomy and survival. Urol Oncol 38(1):7.e9-7.e18CrossRef
26.
Zurück zum Zitat Gong H, Zhou L, Hsueh CY et al (2021) Prognostic value of pathological tumor size in patients with supraglottic carcinoma. Am J Otolaryngol 42(1):102757CrossRef Gong H, Zhou L, Hsueh CY et al (2021) Prognostic value of pathological tumor size in patients with supraglottic carcinoma. Am J Otolaryngol 42(1):102757CrossRef
27.
Zurück zum Zitat Tian S, Li Q, Li R, Chen X, Tao Z, Gong H, Wang X, Hu X (2021) Development and validation of a prognostic nomogram for hypopharyngeal carcinoma. Front Oncol 11:696952CrossRef Tian S, Li Q, Li R, Chen X, Tao Z, Gong H, Wang X, Hu X (2021) Development and validation of a prognostic nomogram for hypopharyngeal carcinoma. Front Oncol 11:696952CrossRef
Metadaten
Titel
Nomograms predicting prognosis for locally advanced hypopharyngeal squamous cell carcinoma
verfasst von
Huiyun Yang
Mengsi Zeng
Sudan Cao
Long Jin
Publikationsdatum
14.10.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 6/2022
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-021-07109-5

Weitere Artikel der Ausgabe 6/2022

European Archives of Oto-Rhino-Laryngology 6/2022 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.